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ABSTRACT
Although hematopoietic precursor activity can be generated in vitro from human embryonic stem cells, there is no solid evidence for the appearance of multipotent, self-renewing and transplantable hematopoietic stem cells. This could be due to short half-life of hematopoietic stem cells in culture or, alternatively, human embryonic stem cell-initiated hematopoiesis may be hematopoietic stem cellindependent similar to yolk sac hematopoiesis, generating multipotent progenitors with limited expansion capacity. Since Myb was reported to be an excellent marker for hematopoietic stem celldependent hematopoiesis, we generated a MYB-eGFP reporter human embryonic stem cell line to study formation of hematopoietic progenitor cells in vitro. We found CD34 + hemogenic endothelial cells rounding up and developing into CD43 + hematopoietic cells without expression of MYB-eGFP.
MYB-eGFP + cells appeared relatively late in embryoid body cultures as CD34 + CD43 + CD45 -/lo cells .
These MYB-eGFP + cells were CD33 positive, proliferated in IL-3 containing media and hematopoietic differentiation was restricted to the granulocytic lineage. In agreement with data obtained on murine
Myb
-/-embryonic stem cells, bright eGFP expression was observed in a subpopulation of cells, during directed myeloid differentiation, which again belonged to the granulocytic lineage. In contrast, CD14 + macrophage cells were consistently eGFP -and were derived from eGFP -precursors only. In summary, no evidence was obtained for in vitro generation of MYB + hematopoietic stem cells during embryoid body cultures. The observed MYB expression appeared late in culture and was confined to the granulocytic lineage.
INTRODUCTION
During embryogenesis, hematopoietic development is spatiotemporally organized in different waves.
During the first, so-called primitive wave of hematopoiesis, nucleated erythrocytes and macrophagelike cells are generated in the yolk sac (YS). Subsequent waves generate multipotent progenitor cells, first in the YS and, finally, in the aorta-gonado-mesonephros region (AGM) where hematopoietic stem cells (HSCs) are generated(1).
Members of the MYB transcription factor family are important transcriptional regulators throughout embryonic development. One of these three family members, MYB, is differentially expressed during embryonic hematopoietic development(2). While Myb transcripts have been detected at low levels during early waves of hematopoiesis, this process is not MYB-dependent. In contrast, HSC-dependent hematopoiesis appears to strictly rely on MYB as loss of function mutants of MYB lead to embryonic lethality due to failure of fetal liver hematopoiesis (3, 4) . In the zebrafish, transgenic animals expressing eGFP under control of myb regulatory elements have been used for visualization and analysis of HSC generation from aortic blood forming hemogenic endothelium(5).
In postnatal life, long term repopulating hematopoietic stem cells (LT-HSC) were found to express the highest levels of Myb and levels decrease progressively in short term repopulating HSC (ST-HSC) and in the multipotent progenitor population (MPP)(6, 7).
MYB-independent hematopoiesis consists largely of short-lived precursors and mature blood cells.
However, the mononuclear phagocyte system (MPS), consisting of brain microglial cells, hepatic
Kupffer cells and skin Langerhans cells, seems to be derived from MYB-independent hematopoietic progenitor cells (HPC) rather than bone marrow-derived MYB-dependent HSC. Recently, Schulz and colleagues have shown that two parallel pathways of macrophage differentiation can be distinguished by their inherent dependence on MYB(8). MYB-independent cells originate in the yolk sac around E7.5-E8.5, possibly from an erythro-myeloid restricted precursor (EMP), while MYB-dependent macrophages originate from bone marrow HSC.
Gene therapeutic strategies for inherited immune deficiencies or other genetic diseases of the blood rely on the assumption that HSC can be generated in vitro from pluripotent stem cells(9). In these approaches, patient-specific induced pluripotent stem cells are generated and the defective gene is corrected by homologous recombination subsequent to targeting the gene defect by zinc-finger nucleases (ZFN) or TALENs. Once the genetic defect is corrected, "cured" HSC are generated by an appropriate in vitro differentiation protocol before infusion. However, current protocols have failed to convincingly demonstrate the generation of HSC in pluripotent stem cell differentiation cultures.
To investigate whether during in vitro human embryonic stem cell (hESC) derived hematopoiesis HSC are formed or rather, hematopoiesis from hESC depends on the emergence of a myb independent EMP-like cell, we generated a MYB reporter line using random integration of a bacterial artificial chromosome (BAC) reporter construct in which eGFP expression is under control of the MYB regulatory DNA sequences.
V a n h e e e t a l . Hematopoietic differentiation of hESC in spin embryoid bodies (EB)
METHODS
To differentiate hESC into hematopoietic cells, the protocol from Ng et al. was used with minor modifications(10). In brief, 5x10 3 single cell-adapted hESC were spun at 480 g into each well of a 96-well low attachment plates and subsequently cultured in APEL medium containing 10 µM Rock inhibitor Y-27632 (Selleckchem, Houston, TX, USA), 40 ng/ml SCF (Peprotech, Rocky Hill, NJ, USA), 2 ng/ml BMP4 (R&D, Minneapolis, MN, USA) and 20 ng/ml VEGF165 (Peprotech), further referred to as "EB mix". After 4 days, spin EB were transferred on an OP9 cell layer and further cultured in EB mix for a total of 7-14 days. Half of the medium was changed on day 7, with APEL medium containing EB mix cytokines, unless a different combination of cytokines is specified. These cytokines were added at following concentrations: 50 ng/ml IL-3 (R&D), 50 ng/ml Flt3-L (R&D), 10 ng/ml TPO (Peprotech) and/or 50 ng/ml IL-6 (R&D).
For myeloid differentiation, spin EBs were dissociated at day 11 and transferred onto OP9 cells in MEM-a with 20% FCS, supplemented with 50 ng/ml SCF (Peprotech), 50 ng/ml TPO (Peprotech), 10 ng/ml IL3 (R&D) and 20 ng/ml IL-6 (R&D). For erythro-megakaryocytic differentiation, spin EBs were dissociated and transferred onto OP9 cells in MEM-a with 20% FCS, supplemented with 50 ng/ml SCF (Peprotech), 50 ng/ml TPO (Peprotech) and 50 ng/ml EPO (eBioscience, San Diego, CA, USA).
Flow cytometry and cell sorting
Flow cytometric analysis was performed on a LSR II system (BD biosciences, San Jose, CA, USA).
Cell sorting was performed with a FACS ARIA IIIU system (BD Biosciences). A list of antibodies used can be found in supplemental materials.
Real time RT-PCR
Cells were lysed and cDNA was synthesized using the SYBR power cells-to-Ct system (Ambion, Life
Technologies, Carlsbad, CA, USA) according to the manufacturer's instructions. Primer sequences can be found in supplemental Table S1 . PCR reagents and SYBR GreenI master were obtained from Roche (Roche, Penzberg, Germany) and used according to the manufacturer's instructions. The reactions were run on a lightcycler480, 384well system (Roche).
Statistical analysis
All statistical analyses were performed using SPSS V22.0 (IBM, New York, USA). Significance was assessed using Mann-Whitney U statistical analysis with significance level set at p ≤ 0.05.
Additional materials and methods are provided in supplemental materials and methods file.
RESULTS
Generation of MYB-eGFP transgenic reporter hESC.
To study MYB expression during hematopoietic differentiation, we generated a MYB-eGFP reporter hESC line using random insertion bacterial artificial chromosome (BAC) transgenesis (supplemental figure 1).
After nucleofection of hESC and neomycin selection, neomycin-resistant hESC colonies were obtained. In figure 1 , data are shown of clone 5, which gave highest eGFP expression and was used in all experiments. Besides the endogenous MYB loci on chromosome 6q, a clear hybridization signal on chromosome 11q was detected on FISH analysis, confirming successful integration of the BAC reporter vector (Figure 1 A) . High-resolution arrayCGH shows integration of the BAC plasmid from Endothelium-derived early hematopoietic precursors are MYB-eGFP negative.
Spin EB cultures were set up and screened daily for the appearance of hematopoietic eGFP + cells.
Expression of CD43, the earliest marker for hematopoietic cells, was first observed in our cultures at day 7. Few eGFP + cells became apparent from day 11 onwards, forming a clear population on day 14.
As shown in Figure2 A To assess expression of genes associated or determining commitment towards the different lineages, RT-qPCR was performed for MPO, GATA1, PU.1 and MPL on the same sorted populations as in To study the generation of the eGFP + precursor at the clonal level, CFU assays and single cell sorting followed by liquid culture were performed on d11 and d14 EB cultures (figure 6). The day11 eGFP -CD34 + CD43 + cell population gave rise to CFU-GEMM, CFU-GM, CFU-G, CFU-M, BFU-E and CFU-E.
These colonies were analyzed microscopically for eGFP expression and it was observed that the CFU-GM, CFU-G and CFU-GEMM contained eGFP positive cells whereas the CFU-M, CFU-E and BFU-E were consistently negative (figure 6 A). Similarly, using single cell culture and flow cytometric analysis, we found that d11 and d14 eGFP
E precursors. A marked skewing towards the myeloid lineage was observed on d14 of culture. In agreement with the CFU assays, eGFP + cell containing wells were confined to the wells containing G, GM and GEMM precursor cells, whereas the wells lacking eGFP expression contained E and M V a n h e e e t a l .
precursors (figure 6 B and 6 C). These data clearly show, that the MYB-eGFP + precursors is a more committed myeloid precursor derived from a multipotent MYB-eGFP -hematopoietic precursor cell.
While macrophage development is MYB-independent, MYB marks granulocytic lineage differentiation.
As MYB was described to be dispensable for the generation of YS derived macrophages, we studied the role of MYB during myeloid lineage choice. When EB cultures were grown under myeloid differentiation conditions, a homogenous population of CD45 + CD33 + was obtained after 4 days of culture (Figure 7 A). To further define both eGFP -and eGFP + populations, we analyzed both populations by flow cytometry, cytospin and qPCR.
The eGFP + population was found to be CD45 lo and positive for CD33, weakly expressing the myeloid markers CD11c, CD11b, CD123 and CD13. The granulocytic marker CD15 was found absent. This phenotype is in line with the surface phenotype of myelocytes, a precursor of the granulocyte lineage.
Macrophage markers CD14, CD16, CD115, HLA-DR and CD86 were consistently negative. On the other hand, the eGFP -population was found to be CD45 1 0 V a n h e e e t a l .
Discussion
We here show evidence that multipotent HPCs expressing high levels of MYB are not generated in human EB cultures initiated with hESC. We therefore conclude that the hematopoietic cells generated in vitro from hESC using current in vitro protocols, emerge through an endothelial intermediate, and cells(17, 18) . Although, to our knowledge, it has not been demonstrated that a single hESC-derived hematopoietic precursor cell is able to form all of the aforementioned cell types, the absence of these reports may be due to technical issues associated with precursor cells of limited proliferative capacity.
The fact that T cells, can be generated from fetal HPC does not in itself prove the presence of multipotent progenitors or HSC, since it has been shown that T cells can be generated from YS precursors that arise before HSC are generated (19, 20 that HSC can be generated from human pluripotent stem cells (23).
In conclusion, based on these data it remains questionable whether HSC can be formed from ESC using currently available in vitro differentiation protocols, although it is clear that multipotent progenitors are formed. Changes to the culture conditions, such as other cytokine mixtures or the use of more appropriate feeder lines may result in HSC generation. The MYB-eGFP cell line that we generated will be very helpful in screening for such conditions. Which factor(s) are missing to generate 1 V a n h e e e t a l .
HSC is unknown to date. However, recent publications using reprogramming of specified cells are Transplantable HSC were shown to express high levels of Myb (6). This is strengthened by the fact that Myb -/-mice die around fetal day 15 due to lack of transplantable HSC (4), moreover, conditional deletion of Myb leads to exhaustion of the stem cell pool and failure to engraft upon transplantation of LSK cells (6).We can therefore conclude that it is unlikely that HSC are generated in these spin EB cultures.
Conditional MYB knockout models show a marked decrease in granulocytic development, suggesting an important role for MYB in granulocytic development(7). In addition, hematopoietic differentiation cultures set up with Myb -/-murine ESC also showed defective granulocyte lineage differentiation (30, 31 
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